Linear IgA-dependent bullous dermatosis


Cite item

Full Text

Abstract

Published data on linear IgA-dependent bullous dermatosis - modern data on the etiology, pathogenesis, and therapy are presented. The authors present their observation of a patient with linear IgA-dependent bullous dermatosis. The clinical picture is described in detail; the disease was diagnosed by standard and other effective noninvasive methods.

About the authors

Natalya P. Teplyuk

I.M. Setchenov First Moscow State Medical University

Email: Teplyukn@gmail.com
V.A. Rakhmanov Department of Skin and Sexually-Transmitted Diseases; MD PhD DSc, prof. 119991, Moscow, Russian Federation

T. A Belousova

I.M. Setchenov First Moscow State Medical University

Email: belka-1147@mail.ru
V.A. Rakhmanov Department of Skin and Sexually-Transmitted Diseases 119991, Moscow, Russian Federation

O. V Grabovskaya

I.M. Setchenov First Moscow State Medical University

Email: olgadoctor@mail.ru
V.A. Rakhmanov Department of Skin and Sexually-Transmitted Diseases 119991, Moscow, Russian Federation

P. M Pyatilova

I.M. Setchenov First Moscow State Medical University

Email: pypolina@mail.ru
V.A. Rakhmanov Department of Skin and Sexually-Transmitted Diseases 119991, Moscow, Russian Federation

A. S Allenova

I.M. Setchenov First Moscow State Medical University

Email: erika-mma@yandex.ru
V.A. Rakhmanov Department of Skin and Sexually-Transmitted Diseases; Research Center 119991, Moscow, Russian Federation

References

  1. Venning V.A. Linear IgA disease: clinical presentation, diagnosis, and pathogenesis. Immunol. Allergy Clin. N. Am. 2012; 32(2): 245-53.
  2. Wojnarowska F., Marsden R.A., Bhogal B., Black M.M. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J. Am. Acad. Dermatol 1988; 19(5, Pt 1): 792-805.
  3. Collier P.M., Wojnarowska F., Welsh K., McGuire W., Black M.M. Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression. Br J. Dermatol. 1999; 141(5): 867-75.
  4. Dellavalle R.P, Burch J.M., Tayal S., Golitz L.E., Fitzpatrick J.E., Walsh P. Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis. J. Am. Acad. Dermatol. 2003; 48(5, Suppl): S56-7.
  5. Collier P.M., Wojnarowska F. Drug-induced linear immunoglobulin A disease. Clin. Dermatol. 1993; 11(4): 529-33.
  6. Palmer R.A., Ogg G., Allen J., Banerjee A., Ryatt K.S., Ratnavel R., Wojnarowska F. Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285. Br J. Dermatol. 2001; 145(5): 816-20.
  7. Camilleri M., Pace J.L. Linear IgA bullous dermatosis induced by piroxicam. J. Eur. Acad. Dermatol. Venereol. 1998; 10(1): 70-2.
  8. Bouldin M.B., Clowers-Webb H.E., Davis J.L., McEvoy M.T., Davis M.D. Naproxen-associated linear IgA bullous dermatosis: case report and review. Mayo Clin. Proc. 2000; 75(9): 967-70.
  9. Herron M., Zone J. Dermatitis herpetiformis and Linear IgA bullous dermatosis. In: Bolognia J., Jorizzo J., Rapini R., eds. Dermatology. Boston: Mosby Elsevier; 2003: 479-87.
  10. Rao C.L., Hall.R.P. Linear IgA Dermatosis and chronic bullous disease of childhood. In: Wolff K., Goldsmith L., Katz S., Gilchrest B.A., Paller A.S., Leffell D.J., eds. Fitzpatrick’s dermatology in general medicine. New York: McGraw Hill Medical; 2008; 485-90.
  11. Baden L., Apovian C., Imber M., Dover J.S. Vancomycin induced linear IgA bullous dermatosis. Arch. Dermatol. 1988; 124(8): 1186-8.
  12. Kuechle M., Stegemeir E., Maynard B., Gibson L.E., Leiferman K.M., Peters M.S. Drug induced linear IgA bullous dermatosis: report of six cases and review of the literature. J. Am. Acad. Dermatol. 1994; 30(2, Pt 1): 187-92.
  13. Nousari H.C., Kimyai-Asadi A., Caeiro J.P., Anhalt G.J. Clinical, demographic, and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin. Report of 2 cases and review of the literature. Medicine (Baltimore). 1999; 78(1): 1-8.
  14. Fortuna G., Salas-Alanis J.C., Guidetti E., Marinkovich M.P. A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: a real and separate nosological entity? J. Am. Acad. Dermatol. 2012; 66(6): 988-94. doi: 10.1016/jjaad.2011.09.018.
  15. Chanal J., Ingen-Housz-Oro S., Ortonne N., Duong T.A., Thomas M., Valeyrie-Allanore L., et al. Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms. Br. J. Dermatol. 2013; 169(5): 1041-8. doi: 10.1111/bjd.12488.
  16. Yhim H.Y., Kwon D.H., Lee N.R., Song E.K., Yim C.Y., Kwak J.Y. Linear IgA bullous dermatosis following autologous PBSC transplantation in a patient with non-Hodgkin’s lymphoma. Bone Marrow Transplant. 2011; 46(1):156-8. doi: 10.1038/bmt.2010.73.
  17. Godfrey K., Wojnarowska F., Leonard J. Linear IgA disease of adults: association with lymphoproliferative malignancy and possible role of other triggering factors. Br. J. Dermatol. 1990; 123(4): 447-52.
  18. Jouan N., Plantin P., Berthou C., Gavanou J., Le Roy J.P., Schollhammer M., et al. Association of IgA linear dermatitis and non-Hogkin’s malignant lymphoma. Rev. Med. Interne. 1992; 13(2): 153-5.
  19. Usmani N., Baxter K.F., Child J.A., Sheehan-Dare R. Linear IgA disease in association with chronic lymphocytic leukaemia. Br. J. Dermatol. 2004; 151(3): 710-1.
  20. Jacyk W.K., Nagel G.J., van der Hoven A.E. Linear IgA dermatosis and Hodgkin’s lymphoma-report of a case in an African and review of the literature. J. Dermatol. 1990; 17(10): 633-7.
  21. Taniguchi T., Maejima H., Saito N., Katsuoka K., Haruki S. Case of linear IgA bullous dermatosis-involved ulcerative colitis. Inflamm. Bowel. Dis. 2009; 15(9): 1284-5. doi: 10.1002/ibd.20795.
  22. Paige D.G., Leonard J.N., Wojnarowska F., Fry L. Linear IgA disease and ulcerative colitis. Br. J. Dermatol. 1997; 136(5): 779-82.
  23. Yamada S., Makino T., Jinnin M., Sakai K., Fukushima S., Inoue Y., et al. Association of linear IgA bullous disease with ulcerative colitis: a case of successful treatment with infliximab. Dermatology. 2013; 227(4): 295-8. doi: 10.1159/000355354.
  24. Birnie A.J., Perkins W. A case of linear IgA disease occurring in a patient with colonic Crohn’s disease. Br. J. Dermatol. 2005; 153(5): 1050-2.
  25. Wozniak K., Kalinska-Bienias A., Hashimoto T., Kowalewski C. UV-induced linear IgA bullous dermatosis: a case report and literature survey. Br. J. Dermatol. 2014; 171(6); 1578-81. doi: 10.1111/bjd.13154.
  26. Baldari U., Raccagni A.A., Celli B., Righini M.G. Chronic bullous disease of childhood following Epstein-Barr virus seroconversion: a case report. Clin. Exp. Dermatol. 1996; 21(2); 123-6.
  27. Simon J.C., Dietrich A., Kapp A., Schopf E. Chronic bullous dermatosis in childhood. Association with salmonella enteritis. Hautarzt. 1995; 46(7); 485-9.
  28. Alberta-Wszolek L., Mousette A.M., Mahalingam M., Levin N.A. Linear IgA bullous dermatosis following influenza vaccination. Dermatol. Online J. 2009; 15(11): 3.
  29. Girao L., Fiadeiro T., Rodrigues J.C. Burn-induced linear IgA dermatosis. J. Eur. Acad. Dermatol. Venereol. 2000; 14(6): 507-10.
  30. Wozniak K., Kalinska-Bienias A., Hashimoto T., Kowalewski C. UV-induced linear IgA bullous dermatosis: a case report and literature survey. Br. J. Dermatol. 2014; 171(6): 1578-81. doi: 10.1111/bjd.13154.
  31. Salmhofer W., Soyer H.P., Wolf P., Fodinger D., Hodl S., Kerl H. UV light-induced linear IgA dermatosis. J. Am. Acad. Dermatol. 2004; 50(1): 109-15.
  32. He C., Xu H., Xiao T., Geng L., Chen H.D. Localized linear IgA dermatosis induced by uV light-treatment for herpes zoster. Int. J. Dermatol. 2007; 46(5): 500-2.
  33. Tobon G.J., Toro C.E., Bravo J.C., Canas C.A. Linear IgA bullous dermatosis associated with systemic lupus erythematosus: a case report. Clin. Rheumatol. 2008; 27(3): 391-3.
  34. Sachs J.A., Leonard J.N., Awad J., McCloskey D., Festenstein H., Hitman G.A., et al. A comparative serological and molecular study of linear IgA disease and dermatitis herpetiformis. Br. J. Dermatol. 1988; 118(6): 759-64.
  35. Leonard J.N., Griffiths C.E., Powles A.V., Haffenden G.P., Fry L. Experience with a gluten free diet in the treatment of linear IgA disease. Acta Derm. Venereol. 1987; 67(2): 145-8.
  36. Leonard J.N., Haffenden G.P, Unsworth D.J., Ring N.P., Holborow E.J., Fry L. Evidence that the IgA in patients with linear IgA disease is qualitatively different from that of patients with dermatitis herpetiformis. Br. J. Dermatol. 1984; 110(3): 315-21.
  37. Hopkinson S.B., Baker S.E., Jones J.C. Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BP180): identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and alpha 6 integrin. J. Cell. Biol. 1995; 130(1): 117-25.
  38. Zone J.J., Taylor T.B., Meyer L.J., Petersen M.J. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. J. Invest. Dermatol. 1998; 110(3): 207-10.
  39. Zone J.J., Pazderka Smith E., Powell D., Taylor T.B., Smith J.B., Meyer L.J. Antigenic specificity of antibodies from patients with linear basement membrane deposition of IgA. Dermatology. 1994; 189 (Suppl. 1): 64-6.
  40. Sakaguchi M., Bito T., Oda Y., Kikusawa A., Nishigori C., Munetsugu T., et al. Three cases of linear IgA/IgG bullous dermatosis showing IgA and IgG reactivity with multiple antigens, particularly laminin-332. J.A.M.A. Dermatol. 2013; 149(11): 1308-13. doi: 10.1001/jamadermatol.2013.5691.
  41. Zenke Y., Nakano T., Eto H., Koga H., Hashimoto T. A case of vancomycin-associated linear IgA bullous dermatosis and IgA antibodies to the a3 subunit of laminin-332. Br. J. Dermatol 2014; 170(4): 965-9.
  42. Haeberle M.T. Linear IgA Dermatosis. http://emedicine.medscape.com/article/1063590-overview. 2014. (Accessed dec. 2014)
  43. Fortuna G., Marinokovich M.P. Linear immunoglobulin A bullous dermatosis. Clin. Dermatol 2012; 30(1): 38-50. doi: 10.1016/j.clindermatol.2011.03.008.
  44. Махнева Н.В. Симптом Никольского в клинике аутоиммунных буллезных дерматозов. Российский журнал кожных и венерических болезней. 2008; 5: 26-29.
  45. Schmid-Wendtner M.H., Burgdorf W. Ultrasound Scanning in Dermatology. Arch Dermatol 2005; 141(2): 217-24.
  46. Wortsman X.C., Holm E.A., Wulf H.C., Jemec G.B. Real-time spatial compound ultrasound imaging of skin. Skin Res. Technol. 2004; 10(1): 23-31.
  47. Потекаев Н.Н., Ткаченко С.Б., Овчинникова А.Ю., Лукашева Н.Н. Конфокальная лазерная сканирующая микроскопия на примере Vivascope 1500: принцип работы и возможности применения в дерматологии. Российский медицинский форум: научный альманах. 2008; 1: 38-43.
  48. Bhogal B., Wojnarowska F., Marsden R.A., Das A., Black M.M., McKee P.H. Linear IgA bullous dermatosis of adults and children: an immunoelectron microscopic study. Br. J. Dermatol. 1987; 117(3): 289-96.
  49. Prost C., De Leca A.C., Combemale P., Labeille B., Martin N., Cosnes A., et al. Diagnosis of adult linear IgA dermatosis by immunoelectronmicroscopy in 16 patients with linear IgA deposits. J. Invest. Dermatol. 1989; 92(1): 39-45.
  50. Allen J., Wojnarowska F. Linear IgA disease: the IgA and IgG response to the epidermal antigens demonstrates that intermolecular epitope spreading is associated with IgA rather than IgG antibodies, and is more common in adults. Br. J. Dermatol. 2003; 149(5): 977-85.
  51. Wojnarowska F. Linear IgA dapsone responsive bullous dermatosis. J. R. Soc. Med. 1980; 73(5): 371-3.
  52. Ng S.Y., Venning V.V. Management of linear IgA disease. Dermatol. Clin. 2011; 29(4): 629-30. doi: 10.1016/j.det.2011.06.014.
  53. Young H., Coulson I. Linear IgA disease: successful treatment with cyclosporine. Br. J. Dermatol 2000; 143(1): 204-5.
  54. Потекаев H.C., Кочергин Н.Г., Теплюк Н.П., Паничкина Г.С., Заборова В.А., Лысенко Л.В., Миченко А.В. Терапевтическая тактика при стероидрезистентной пузырчатке. Российский журнал кожных и венерических болезней. 2003; 2: 11-16.
  55. Klein P.A., Callen J.P. Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency. J. Am. Acad. Dermatol. 2000; 42(2 Pt 2):316-23.
  56. Потекаев Н.С., Махнева Н.В., Теплюк Н.П. Современная терапия аутоиммунной пузырчатки и превентивные меры осложнений; Методические рекомендации, М.: MMA; 2013.

Copyright (c) 2015 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies